Imagine the temptation: You are present at a highly confidential briefing where you learn that a developing pandemic is likely to wreak havoc on the American economy. What do you do? What can you do?

As we have seen from recent press reports, this is not just a theoretical question, as it appears that certain members of Congress sold stock after attending a series of confidential congressional briefings around the threat of the novel coronavirus beginning in late January, before the stock market plummeted. But in these times of market volatility, a similar situation could take place in different ways at many different companies.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]